Sequential Enrolment in Donation and Transplantation Trials
- Logistics
- Virtual
- Anticipated time commitment
- Approximately 9 hours total over a 3-5 month period.
- Application deadline
- Type of Organ
- Heart, Kidney, Liver, Lung, Pancreas
- Opportunity Type
- Research Partner
- Theme
- T1 - Culture of Donation, T2 - Practices for Donation, T3 - Better Grafts, T4 - Optimizing Immune Systems
Internationally and in Canada, clinical trials addressing deceased donor interventions are on the rise. Often, the goal of donor interventions is to improve transplant outcomes. This is frequently the goal of other clinical trials that enrol transplant recipients.
It's possible that there will be reasons that a donor should not be enrolled into a clinical trial if the recipient will be enrolled in a related or "competing" trial. The corollary is also true; it's possible that a recipient should not be enrolled in a trial if the donor was in a related "competing" trial.
We aim to develop national guidelines to facilitate these deliberations and to ensure the safe application of "sequential research enrolment" when suitable.
We would like to incorporate the views of various transplant recipients, those on a transplant wait list, and deceased donor families in the development of this guideline.
Experience required
This project seeks to include donor families, transplant recipients and patients on a transplant waitlist with lived experience with kidney, liver, lung, heart, or pancreas disease or transplantation.
Potential roles for PFD Partners
The PFD Research Partners will bring their lived experiences and perspectives to the guideline panel. They will collaborate with others on the guideline panel, including donation researchers, transplant researchers, ethicists, and statisticians. You will be an equal member of this panel whose perspectives and voice will influence the guideline paper.
PFD Partners will commit to the following over a 3-5 month period.
- Attend a learning webinar (1 hour)
- Read some background materials (2 hours)
- Attend 3-4 guideline panel meetings. (4-5hours)
- Critically review the final guideline paper (1 hours)
Reimbursement
Following CDTRP's Terms of Reference, we will remunerate PFD partners $50 per hour.
How to get in touch
- Name
- Maureen Meade, MD
- Job title
- Principal investigator
- meadema@mcmaster.ca
If you are interested in participating in this project and have questions, please email us at meadema@mcmaster.ca and CC mescoto@cdtrp.ca.